Culture

Rare lichen unique to Florida discovered in museum collections, may be extinct

image: The only records of the newly-identified lichen Cora timucua are 32 specimens in museum collections collected in Florida between 1885 and 1985. Up to 90% of its native pine scrub habitat has been replaced by citrus groves or urbanization.

Image: 
Robert Lücking

GAINESVILLE, Fla. --- Scientists have found a new species of fleshy verdigris lichen, thanks to DNA analysis of museum specimens. Misidentified by its original collectors, the lichen is only known from 32 specimens collected in North and Central Florida scrubland between 1885 and 1985. Now the hunt is on to find it in the wild - if it still exists.

The lichen, named Cora timucua in honor of Florida's Timucua people, is critically endangered, even more so than the federally protected Florida perforate reindeer lichen, and possibly extinct. Researchers are holding out hope that C. timucua may persist in undisturbed pockets of the state's dwindling pine scrub habitat, though recent searches came up empty.

"The million-dollar question is 'Where is this lichen?'" said Laurel Kaminsky, a digitization manager at the Florida Museum of Natural History and co-author of the study. "The optimist in me says it's still out there."

Kaminsky said the sparse information recorded by the lichen's collectors makes it difficult to retrace their steps. More widespread in the early 20th century, C. timucua was collected only from the Ocala National Forest and O'Leno State Park after 1968, two of Florida's last remaining scrub ecosystems. Citrus groves and urban developments have replaced up to 90% of the state's sand pine scrub.

"If it's anywhere, it's going to take a lot of looking in very specific habitats to find it," Kaminsky said.

Affectionately dubbed "Timucua heart lichen," the new species resembles a shelf fungus and is about the size of a sand dollar with scalloped edges. It can be distinguished from wood-rotting fungi by its texture: felty and papery, with curved lobes and a cracked underside.

But its color is an enigma. The lichen is light gray when dry, but specimens turn a deep blue-green and bleed a reddish-brown pigment when wet in a laboratory setting. Without photos and detailed descriptions of the lichen in nature, scientists don't yet know how it reacts to moisture in the wild.

"In general, people take nature for granted, and the Timucua heart lichen story might tell us sometimes we are too late," said Manuela Dal Forno, senior author of the study and a lichenologist at the Botanical Research Institute of Texas. "Right now, we need everybody's help in trying to locate this lichen in Florida."

Kaminsky said Timucua heart lichen likely prefers old-growth pine scrub habitat, which has taller trees and established populations of native Florida plants, such as rusty lyonia, a shrub characterized by reddish fibers lining its leaves. But hikers should avoid collecting any potential specimens they find: Instead, they can photograph the lichen and upload images to the Timucua Heart Lichen Project on the community science platform iNaturalist for identification.

Florida's hidden lichen life

Lichens are partnerships between fungi and photosynthesizing organisms and play a key role in their ecosystems by enriching soils and cycling nutrients. But much of the world's lichen diversity remains hidden. A chronic shortage of lichen experts led to the delay in Timucua heart lichen's discovery, Kaminsky said. She added that Florida could harbor as many as 1,000 lichen species, many of which remain undescribed and whose populations could also be imperiled.

A previous survey of South Florida's Fackahatchee Strand Preserve led by Robert Lücking, a curator at Berlin's Botanical Garden and Botanical Museum and lead author of the C. timucua study, found more than 400 lichen species in about 250 acres. Of the 400 species, 18 were new to science and 100 had yet to be recorded in North America.

"This emphasizes how little we know about lichen diversity and their genetic information, as well as the importance of digitization projects," said Dal Forno, also a research associate at the Smithsonian's National Museum of Natural History. "There are so many lichens out there, but not enough lichenologists to study them."

Timucua heart lichen belongs to the genus Cora, a group of nearly 200 tropical lichens - once thought to be a single species - typically found in mountain habitats. Its discovery in Florida is the northernmost record of a Cora species, and the new species is the sole representative of its genus in the U.S.

Even if the species is extinct, studying its DNA could help scientists understand how the species arrived in Florida. Timucua heart lichen's closest known relatives are in Colombia and Brazil, raising questions about how C. timucua was able to grow in a habitat so different from its sister species, Dal Forno said.

Digital museum specimens led to discovery

Increasingly, researchers need not pack a tent and head into the field to find new species. Instead, they can search online databases of specimen data from museums around the world. In 2012, a National Science Foundation grant helped scientists digitize lichens from the Florida Museum's fungal herbarium, uploading basic specimen information and images to two international data networks, the Global Biodiversity Information Facility and the Consortium of North American Lichen Herbaria.

It was on the web that Lücking and Gary Perlmutter, acting curator of lichens at the University of North Carolina at Chapel Hill herbarium and a study co-author, spotted clusters of Florida Cora specimens, far outside the genus's known range. They contacted Kaminsky, suspecting DNA analysis would uncover misidentified specimens.

"I knew we had these specimens, but I just thought everybody else knew," Kaminsky said. "The digitization just opened it up for other people to find it and do cool things with it."

Credit: 
Florida Museum of Natural History

Understanding future species distribution: new data for biogeographers

image: Example of BIO34 - Potential Evapotranspiration (PET, mm/y) according to Hargreaves formulation for historical time interval 1960-1999 (left). Ensemble anomaly of the 11 CMIP5 simulations for the future period compared to the historical one expressed in percentage (center) and the variation among simulation expressed in Relative Standard Deviation (RSD) (right) for the two time horizons 2040-2079 (top) and 2060-2099 (bottom).

Image: 
Noce, S., Caporaso, L. & Santini, M. A new global dataset of bioclimatic indicators. Sci Data 7, 398 (2020). https://doi.org/10.1038/s41597-020-00726-5 Creative Commons License: CC BY

Climate change impacts, affecting primarily ecosystems' functions and consequently human sectors, have become a crucial topic. Observed and expected variations in climate conditions can in fact undermine the ecosystems' ecological equilibrium: average climate patterns, mainly represented by intra-annual (monthly to seasonal) temperature and precipitation cycle, directly influence the distribution, abundance and interactions of biological species.

During the long history of scientific research on the relationships between climate and Earth's communities, numerous meteorological variables and/or derived indices have been formulated, calculated and applied to explain the geographic distribution of natural populations along climate gradients, characterized by intra-annual patterns of temperature and precipitation. Such variables and indices are also known as bioclimatic indicators (BioClimInd). They mainly result from primary - observed or modelled - climate fields (e.g. minimum, maximum and mean temperature, precipitation amount) and contribute to delineate the bioclimatic "envelope" for species in terms of favourable environmental conditions, also referred to as "suitability.

A study led by the CMCC Foundation and recently published on the Nature Journal Scientific Data released a new global and free access dataset of bioclimatic indicators at 0.5° by 0.5° spatial resolution (ca. 50 km at the equator) for historical and future conditions. "Our target was to widen the availability of bioclimatic information by an ensemble of bioclimatic indicators valuable both for historical and future robust climate change impacts' assessments", explains Sergio Noce, CMCC scientist and lead author of the study. His research at CMCC focuses on the analysis of the potential impacts of climate change on spatial distribution of forest species. "We're thinking about a wide range of research fields such as wildlife ecology, natural resources' conservation and management, botanic, forestry and many other fields involving biogeography. More in general, our data could be useful for all studies using species distribution modelling. Considering its spatial resolution, this dataset will be especially suitable for studies at continental - global scale, for example, to study regions such as the Mediterranean or the Russian territory; even before releasing the dataset, our team published a work on the impacts of global warming on Russian forests from a biogeographical perspective using these bioclimatic indicators".

What is meant by biogeography and why bioclimatic indicators are so important? As he explained in his Nature Behind the paper article, "Biogeography studies the distribution of species and ecosystems in a geographic space and the relationships between these communities and, among others, the climatic conditions: bioclimatic indicators summarize these conditions. Changes in species distribution has always occurred; there are many examples of animal or plant species that 'migrated' towards more suitable environmental and climatic conditions in the past. To make an example, starting from the end of the most recent glaciation (approx 11-12,000 years B.P.) the European hazel were only in some glacial refugia in southern Europe; as climate was getting warmer, hazel started to migrate north and spread in all the European continent. Climate change accelerated this processes and today understanding and being able to forecast future climate envelopes, that is understanding how species distribution and occurrence will change in the future, is becoming always more important."

The new dataset, called CMCC-BioClimInd, will contribute to achieve this goal while providing a set of 35 bioclimatic indices calculated both for a 40-years historical interval (1960-1999) and for two future time horizons (mid-term 2040-2079 and long-term 2060-2099) from, respectively, post-processing of climate reanalysis and an ensemble of 11 Coupled Model Intercomparison Project Phase 5 (CMIP5) bias corrected climate simulations.

Therefore the new CMCC dataset of bioclimatic indicators will be useful to a broad community of researchers aiming at reproducing and modelling, respectively, current and future habitats' ranges by mean of a Species Distribution Modelling (SDM) approach, where large amount of high quality and up-to-date environmental (especially climate) data is required.

"On the one hand", Noce concludes, "the exploitation of indicators instead of just raw climate variables enables easier inferring of relationships between the studied topic (species occurrence, resources availability etc.) and the climate regime to support decision for complex systems; on the other hand, using the ensemble allows considering the variability across simulations due to the different models' physics and the uncertain future development pathways."

The work is ongoing and in the near future, CMCC researchers wish to keep CMCC-BioClimInd up-to-date adding more climate simulations and/or further model outputs.

The data of individual indicators are publicly available for download in the commonly used Network Common Data Form 4 (NetCDF4) format in CMCC Data Delivery System (CMCC DDS) just released online, a unique, consistent and seamless access point for all data produced and used by CMCC.

Credit: 
CMCC Foundation - Euro-Mediterranean Center on Climate Change

Metformin use reduces risk of death for patients with COVID-19 and diabetes

image: Anath Shalev

Image: 
UAB

BIRMINGHAM, Ala. - Use of the diabetes drug metformin -- before a diagnosis of COVID-19 -- is associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes, according to a racially diverse study at the University of Alabama at Birmingham. Diabetes is a significant comorbidity for COVID-19.

"This beneficial effect remained, even after correcting for age, sex, race, obesity, and hypertension or chronic kidney disease and heart failure," said Anath Shalev, M.D., director of UAB's Comprehensive Diabetes Center and leader of the study.

"Since similar results have now been obtained in different populations from around the world -- including China, France and a UnitedHealthcare analysis -- this suggests that the observed reduction in mortality risk associated with metformin use in subjects with Type 2 diabetes and COVID-19 might be generalizable," Shalev said.

How metformin improves prognosis in the context of COVID-19 is not known, Shalev says. The UAB findings suggest that the mechanisms may go beyond any expected improvement in glycemic control or obesity, since neither body mass index, blood glucose nor hemoglobin A1C were lower in the metformin users who survived as compared to those who died.

"The mechanisms may involve metformin's previously described anti-inflammatory and anti-thrombotic effects," Shalev said.

The study -- first made available in MedRxiv and now published in the peer-reviewed journal Frontiers in Endocrinology -- included 25,326 patients tested for COVID-19 at the tertiary care UAB Hospital between Feb. 25 and June 22 of last year. Of the 604 patients found to be COVID-19-positive, 311 were African Americans.

The primary outcome in the study was mortality in COVID-19-positive subjects, and the potential association with subject characteristics or comorbidities was analyzed.

Researchers found that Blacks, who are only 26 percent of Alabama's population, were 52 percent of those who tested positive for COVID-19, and only 30 percent of those who tested negative. In contrast, only 36 percent of the COVID-19-positive subjects were white, while whites made up 56 percent of those who tested negative, further underlining the racial disparity. Once COVID-19-positive though, no significant racial difference in mortality was observed.

"In our cohort," Shalev said, "being African American appeared to be primarily a risk factor for contracting COVID-19, rather than for mortality. This suggests that any racial disparity observed is likely due to exposure risk and external socioeconomic factors, including access to proper health care."

Overall mortality for COVID-19-positive patients was 11 percent. The study found that 93 percent of deaths occurred in subjects over the age of 50, and being male or having high blood pressure was associated with a significantly elevated risk of death. Diabetes was associated with a dramatic increase in mortality, with an odds ratio of 3.62. Overall, 67 percent of deaths in the study occurred in subjects with diabetes.

The researchers looked at the effects of diabetes treatment on adverse COVID-19 outcomes, focusing on insulin and metformin as the two most common medications for Type 2 diabetes. They found that prior insulin use did not affect mortality risk.

However, prior metformin use was a different matter. Metformin use significantly reduced the odds of dying, and the 11 percent mortality for metformin users was not only comparable to that of the general COVID-19-positive population, it was dramatically lower than the 23 percent mortality for diabetes patients not on metformin.

After controlling for other covariates, age, sex and metformin use emerged as independent factors affecting COVID-19-related mortality. Interestingly, even after controlling for all these other covariates, death was significantly less likely -- with an odds ratio of 0.33 -- for Type 2 diabetes subjects taking metformin, compared with those who did not take metformin.

"These results suggest that, while diabetes is an independent risk factor for COVID-19-related mortality," Shalev said, "this risk is dramatically reduced in subjects taking metformin -- raising the possibility that metformin may provide a protective approach in this high-risk population."

The researchers say future studies will need to explore how metformin is protective, as well as assess the risks and benefits of metformin treatment and the indications for its use in the face of the ongoing COVID-19 pandemic.

Credit: 
University of Alabama at Birmingham

Common workplace interactions can trigger suicidal thoughts for employees with mood disorders

image: Kayla Follmer

Image: 
West Virginia University

Ignoring a colleague's greeting or making a sarcastic comment in the workplace may actually do more harm than intended, according to West Virginia University research.

Perceived low-grade forms of workplace mistreatment, such as avoiding eye contact or excluding a coworker from conversation, can amplify suicidal thoughts in employees with mood disorders, based on a study by Kayla Follmer, assistant professor of management, and Jake Follmer, assistant professor of educational psychology.

"We know from prior research that minor forms of workplace mistreatment reduce employee engagement," Kayla Follmer said. "But our paper provided an explanation for why this was occurring. Mistreatment increases suicidal ideation (thoughts) and because of that, work engagement is reduced."

The research team surveyed 279 American adults who are employed 20 or more hours a week and diagnosed with depression or bipolar disorder.

"What we wanted to do was hone in on employees most likely to experience these effects because that gives us greater opportunity for intervention," she said.

The researchers then asked participants to rate various experiences relating to workplace mistreatment, suicidal ideation, and job engagement over several months.

Kayla Follmer believes this is the first study that links these types of workplace mistreatments to potentially serious psychological outcomes. Their findings are published in Organizational Behavior and Human Decision Processes.

"These actions are not egregious or illegal," she said. "It's not even considered bullying or harassment. These are ways, on a day-to-day basis, that you might hurt somebody but in a low-grade way. It's how we may behave and we don't think twice about it."

Another finding from the study suggests that these effects are stronger for those not receiving treatment for their depression or mood disorder. Kayla Follmer estimated that roughly 50 percent of participants fit into that category.

Mental health in the workplace is one of her areas of expertise. A trained industrial organizational psychologist, she considers the topic overlooked in management research and the business world, in general.

"We all focus on bottom lines and productivity but we fail to take into account employee experiences and the effect mental illness can have on those experiences," she said.

In turn, organizations can enhance the workplace environment by providing mental health resources to employees, which may increase production and job satisfaction.

While research for this study was conducted before the COVID-19 pandemic, Kayla Follmer wonders if the world of remote work intensifies the effects of mental health and workplace engagement.

She theorized that employees no longer working in a traditional office setting because of the pandemic may feel less engaged.

And virtual communication can be easily misconstrued, adding a layer of instability.

"In some ways, our results may be even more important now because we know that depression and anxiety are at the highest levels they've been," she said.

"Suicide and depression are very taboo, dark topics. It can be heavy at times to research, but that's the responsibility we bear to bring these experiences into awareness for organizations and to tell them we can do better. And it's our responsibility to do better for those individuals who need us."

Credit: 
West Virginia University

Research breaks new ground in understanding how a molecular motor generates force

image: Ned Debold is an associate professor of kinesiology in the UMass Amherst School of Public Health and Health Sciences.

Image: 
UMass Amherst

A team of biophysicists from the University of Massachusetts Amherst and Penn State College of Medicine set out to tackle the long-standing question about the nature of force generation by myosin, the molecular motor responsible for muscle contraction and many other cellular processes. The key question they addressed - one of the most controversial topics in the field - was: how does myosin convert chemical energy, in the form of ATP, into mechanical work?

The answer revealed new details into how myosin, the engine of muscle and related motor proteins, transduces energy.

In the end, their unprecedented research, meticulously repeated with different controls and double-checked, supported their hypothesis that the mechanical events of a molecular motor precede - rather than follow - the biochemical events, directly challenging the long-held view that biochemical events gate the force-generating event. The work, published in the Journal of Biological Chemistry, was selected as an Editor's Pick for "providing an exceptional contribution to the field."

Completing complementary experiments to examine myosin at the most minute level, the scientists used a combination of technologies - single molecule laser trapping at UMass Amherst and FRET (fluorescence resonance energy transfer) at Penn State and the University of Minnesota. The team was led by muscle biophysicist Edward "Ned" Debold, associate professor in the UMass Amherst School of Public Health and Health Sciences; biochemist Christopher Yengo, professor at Penn State College of Medicine; and muscle biophysicist David Thomas, professor in the College of Biological Sciences at the University of Minnesota.

"This was the first time these two cutting-edge techniques have been combined together to study a molecular motor and answer an age-old question," Debold says. "We've known for 50 years the broad scope of how things like muscle and molecular motors work, but we didn't know the details of how that occurs at the most minute level, the nanoscale motions. It's like we're looking under the hood of a car and examining how the engine works. How does it take the fuel and convert it into work when you press the gas pedal?"

Using his single molecule laser trap assay in his lab, Debold and his team, including graduate students Brent Scott and Chris Marang, were able to directly observe the size and rate of myosin's nanoscale mechanical motions as it interacted with a single actin filament, its molecular partner in force generation. They observed that the force-generating step, or powerstroke, happened extremely fast, almost as soon as it bound to the actin filament.

In parallel experiments using FRET assays, Yengo's team confirmed this fast rate of the powerstroke and with additional studies demonstrated that the key biochemical steps happened subsequently and much more slowly. Further analysis revealed for the first time how these events might be coordinated by the intramolecular motions deep inside the myosin molecule.

"Chris Yengo collected his data separate from mine and we combined and integrated the results," Debold says. "I could see things that he couldn't, and he could see things that I couldn't, and in combination we were able to reveal novel insights into how a molecular motor transduces energy. It was clear that the mechanics happened first followed by the biochemical events."

Highlighting the importance of examining energy transduction at the nanoscale level has very broad implications, Debold explains. "It's not just about how muscle works," he says. "It is also a window into how many motor enzymes within our cells transduce energy, from those that drive muscle contraction to those that cause a cell to divide."

Detailed knowledge about that process could help scientists one day develop treatments for such conditions as heart failure, cancer and more. "If you understand how the molecular motor works, you could use that information to improve function when it's compromised, as in the case of heart failure," Debold says. "Or if you wanted to prevent a tumor cell from dividing, you could use this information to prevent force-generation. Knowing exactly how force-generation occurs could be very useful for somebody trying to develop a drug to inhibit a molecular motor during cell division, and ultimately cancer."

Credit: 
University of Massachusetts Amherst

Researchers rewind the clock to calculate age and site of supernova blast

image: This Hubble Space Telescope portrait reveals the gaseous remains of an exploded massive star that erupted approximately 1,700 years ago. The stellar corpse, a supernova remnant named 1E 0102.2-7219, met its demise in the Small Magellanic Cloud, a satellite galaxy of our Milky Way.

Image: 
Credits: NASA, ESA, and J. Banovetz and D. Milisavljevic (Purdue University)

Astronomers are winding back the clock on the expanding remains of a nearby, exploded star. By using NASA's Hubble Space Telescope, they retraced the speedy shrapnel from the blast to calculate a more accurate estimate of the location and time of the stellar detonation.

The victim is a star that exploded long ago in the Small Magellanic Cloud, a satellite galaxy to our Milky Way. The doomed star left behind an expanding, gaseous corpse, a supernova remnant named 1E 0102.2-7219, which NASA's Einstein Observatory first discovered in X-rays. Like detectives, researchers sifted through archival images taken by Hubble, analyzing visible-light observations made 10 years apart.

The research team, led by John Banovetz and Danny Milisavljevic of Purdue University in West Lafayette, Indiana, measured the velocities of 45 tadpole-shaped, oxygen-rich clumps of ejecta flung by the supernova blast. Ionized oxygen is an excellent tracer because it glows brightest in visible light.

To calculate an accurate explosion age, the astronomers picked the 22 fastest moving ejecta clumps, or knots. The researchers determined that these targets were the least likely to have been slowed down by passage through interstellar material. They then traced the knots' motion backward until the ejecta coalesced at one point, identifying the explosion site. Once that was known, they could calculate how long it took the speedy knots to travel from the explosion center to their current location.

According to their estimate, light from the blast arrived at Earth 1,700 years ago, during the decline of the Roman Empire. However, the supernova would only have been visible to inhabitants of Earth's southern hemisphere. Unfortunately, there are no known records of this titanic event.

The researchers' results differ from previous observations of the supernova's blast site and age. Earlier studies, for example, arrived at explosion ages of 2,000 and 1,000 years ago. However, Banovetz and Milisavljevic say their analysis is more robust.

"A prior study compared images taken years apart with two different cameras on Hubble, the Wide Field Planetary Camera 2 and the Advanced Camera for Surveys (ACS)," Milisavljevic said. "But our study compares data taken with the same camera, the ACS, making the comparison much more robust; the knots were much easier to track using the same instrument. It's a testament to the longevity of Hubble that we could do such a clean comparison of images taken 10 years apart."

The astronomers also took advantage of the sharp ACS images in selecting which ejecta clumps to analyze. In prior studies, researchers averaged the speed of all of the gaseous debris to calculate an explosion age. However, the ACS data revealed regions where the ejecta slowed down because it was slamming into denser material shed by the star before it exploded as a supernova. Researchers didn't include those knots in the sample. They needed the ejecta that best reflected their original velocities from the explosion, using them to determine an accurate age estimate of the supernova blast.

Hubble also clocked the speed of a suspected neutron star--the crushed core of the doomed star--that was ejected from the blast. Based on their estimates, the neutron star must be moving at more than 2 million miles per hour from the center of the explosion to have arrived at its current position. The suspected neutron star was identified in observations with the European Southern Observatory's Very Large Telescope in Chile, in combination with data from NASA's Chandra X-ray Observatory.

"That is pretty fast and at the extreme end of how fast we think a neutron star can be moving, even if it got a kick from the supernova explosion," Banovetz said. "More recent investigations call into question whether the object is actually the surviving neutron star of the supernova explosion. It is potentially just a compact clump of supernova ejecta that has been lit up, and our results generally support this conclusion."

So the hunt may still be on for the neutron star. "Our study doesn't solve the mystery, but it gives an estimate of the velocity for the candidate neutron star," Banovetz said.

Credit: 
NASA/Goddard Space Flight Center

Acute itching in eczema patients linked to environmental allergens

image: Research at Washington University School of Medicine in St. Louis indicates that cells in the blood called basophils (brown in illustration) can react to allergens (round honeycomb shapes) in the environment and send itch signals to nerve cells, leading to episodes of severe itch in eczema patients that can't be treated by antihistamines.

Image: 
Illustration by Madison Mack

In addition to a skin rash, many eczema sufferers also experience chronic itching, but sometimes that itching can become torturous. Worse, antihistamines -- the standard treatment for itching and allergy -- often don't help.

New research from Washington University School of Medicine in St. Louis indicates that allergens in the environment often are to blame for episodes of acute itch in eczema patients, and that the itching often doesn't respond to antihistamines because the itch signals are being carried to the brain along a previously unrecognized pathway that current drugs don't target.

The new findings, published Jan. 14 in the journal Cell, point to a possible new target and strategy to help eczema patients cope with those episodes of acute, severe itch.

"Years ago, we used to think that itch and pain were carried along the same subway lines in the nerves to the brain, but it turned out they weren't, and these new findings show there's another pathway entirely that's causing these episodes of acute itching in eczema patients," said principal investigator Brian S. Kim, MD, a dermatologist and an associate professor of medicine. "The itch can be maddening. Patients may rate their chronic itch at around a 5 on a scale of 10, but that goes up to 10 during acute itch flares. Now that we know those acute flares are being transmitted in an entirely different way, we can target that pathway, and maybe we can help those patients."

The typical pathway for itching in eczema patients involves cells in the skin that are activated and then release histamine, which can be inhibited with antihistamine drugs. But with this acute itching, a different type of cell in the bloodstream transmits itch signals to the nerves. Those cells produce too much of another non-histamine substance that triggers itch; therefore, antihistamines don't work in response to such signals.

"We've connected acute itching in eczema to allergic reactions transmitted by an entirely different population of cells," said Kim, also the co-director of the Center for the Study of Itch & Sensory Disorders. "In patients who experience episodes of acute itching, their bodies react in the same way as in people with acute allergy. If we can block this pathway with drugs, it might represent a strategy for treating not only itch but other problems, including perhaps hay fever and asthma."

In recent years, several clinical studies have tested a strategy that involves blocking Immunoglobulin E (IgE), a substance produced by the immune system in response to allergens. Patients with allergies produce IgE, causing allergic reactions, but its role in itch has been unclear.

Reviewing data from clinical studies of drugs aimed at treating chronic itching, Kim found a pattern in which patients reported episodes of acute itching, often after exposure to environmental allergens. He also found that eczema patients who make IgE in response to allergens in the environment were more likely to experience those episodes of severe, acute itch.

"Environmental allergens actually promote this type of itch," he explained. "Say a patient with eczema goes to Grandma's house, where there's a cat, and that person's itching just goes crazy. It's likely cat dander is activating IgE, and IgE is activating itch."

Kim's team took these observations to the laboratory, where his team made a mouse model of eczema. Studying the animals, they found that when the mice made IgE, they began to itch. But unlike standard itch signals, in which cells in the skin called mast cells release histamine, the IgE in mice with eczema activated a type of white blood cell called a basophil. Those cells then activated an entirely different set of nerve cells than the cells that carry itch signals that respond to antihistamines.

The discovery that acute itching in eczema is linked to exposure to allergens may help them avoid things that make them itch intensely, including animals, dust, mold or certain foods. Meanwhile, it also offers drug companies new targets for treating itch in eczema patients, including proteins and molecules Kim's team has identified along this newly identified neuro-immune pathway.

Credit: 
Washington University School of Medicine

Astronomers document the rise and fall of a rarely observed stellar dance

image: An image from the Digitized Sky Survey showing HS Hydrae in the center.

Image: 
Space Telescope Science Institute

The sun is the only star in our system. But many of the points of light in our night sky are not as lonely. By some estimates, more than three-quarters of all stars exist as binaries -- with one companion -- or in even more complex relationships. Stars in close quarters can have dramatic impacts on their neighbors. They can strip material from one another, merge or twist each other's movements through the cosmos.

And sometimes those changes unfold over the course of a few generations.

That is what a team of astronomers from the University of Washington, Western Washington University and the University of California, Irvine discovered when they analyzed more than 125 years of astronomical observations of a nearby stellar binary called HS Hydrae. This system is what's known as an eclipsing binary: From Earth, the two stars appear to pass over one another -- or eclipse one another -- as they orbit a shared center of gravity. The eclipses cause the amount of light emitted by the binary to dim periodically.

On Jan. 11 at the 237th meeting of the American Astronomical Society, the team reported more than a century's worth of changes to the eclipses by the stars in HS Hydrae. The two stars began to eclipse in small amounts starting around a century ago, increasing to almost full eclipses by the 1960s. The degree of eclipsing then plummeted over the course of just a half century, and will cease around February 2021.

"There is a historical record of observations of HS Hydrae that essentially spans modern astronomy -- starting with photographic plates in the late 19th century up through satellite images taken in 2019. By diving into those records, we documented the complete rise and fall of this rare type of eclipsing binary," said team leader James Davenport, a research assistant professor of astronomy at the UW and associate director of the UW's DIRAC Institute.

The eclipses of the two stars that make up HS Hydrae are changing because another body -- most likely a third, unobserved companion star -- is turning the orientation of the binary with respect to Earth. Systems like this, which are called evolving eclipsing binaries, are rare, with only about a dozen known to date, according to Davenport. Identifying this type of binary requires multiple observations to look for long-term changes in the degree of dimming, which would indicate that the orientation of the binary is changing over time.

HS Hydrae has such an observational record because, at 342 light- years away, it is a relatively close and bright system and the two stars orbit each other every 1.5 days. Scientists first reported that HS Hydrae was an eclipsing binary in 1965. In a 2012 paper, astronomers based in Switzerland and the Czech Republic reported that the amount of dimming from HS Hydrae decreased from 1975 through 2008, indicating that the two stars were eclipsing smaller and smaller portions of one another over time. That team also predicted that the eclipses would end around 2022.

Davenport and his team checked in on HS Hydrae using observations of the system in 2019 by the NASA's Transiting Exoplanet Survey Satellite, or TESS. They saw only a 0.0075-magnitude drop in light from HS Hydrae, a sign that the two stars were barely covering one another during eclipses. For comparison, eclipses in 1975 saw a more than 0.5-magnitude drop.

"Fifty years ago, these two stars were almost completely eclipsing each other. By the early 21st century, the degree of eclipse was around 10%, and in the most recent observations from 2019, they barely overlapped," said Davenport.

With these new data, the team now predicts that HS Hydrae eclipses will cease around February 2021.

The observations from the 1960s through 2019 catalogue the decline of HS Hydrae as an evolving eclipsing binary. But Davenport and his team also uncovered evidence for its rise. The Digital Access to a Sky Century at Harvard, or DASCH, is a digital catalog of photometric data taken from more than a century's worth of astro-photographic plates at Harvard University. The team mined this record and found observations of HS Hydrae from 1893 through 1955 that they could analyze to search for signs of dimming.

The researchers broke down DASCH observations of HS Hydrae by decade. From the late 19th century through the roaring '20s, HS Hydrae showed no measurable dimming. But things began to change in the 1930s, where they measured a modest 0.1-magnitude drop in brightness. The degree of dimming rose through the 1940s and peaked in the 1950s with a 0.5-magnitude drop in brightness.

Based off this 126-year history of HS Hydrae observations, the team predicts that the system will start eclipsing again around the year 2195. But, that assumes that the third companion -- which other teams have predicted is a small, dim M-dwarf star -- continues to behave as it has to date.

"We won't know for sure unless we keep looking," said Davenport. "The best we can say right now is that HS Hydrae has been changing constantly over the course of modern astronomy."

Missions like TESS will likely identify more evolving eclipsing binaries in the coming years. This should open new opportunities for astronomers to understand how star systems are built, as well as how they change over time -- whether they are busy, dynamic systems like HS Hydrae, or more quiet systems, like ours.

Credit: 
University of Washington

Scientists uncover new path toward treating a rare but deadly neurologic condition

BOSTON - Studies with a popular laboratory model, the nematode Caenorhabditis elegans, have revealed a possible therapeutic avenue for a rare but deadly condition in which children are born without the ability to make molybdenum cofactor (Moco) on their own.

Though little known, Moco is essential for life and so far it has proven extremely difficult to stably isolate this compound in the laboratory, preventing its use as a therapeutic supplement. This new work, which appears in Genes & Development, reveals that nematodes genetically engineered to be Moco-deficient can take up Moco that is attached to several types of proteins. This suggests that such protein-Moco complexes could be used as a treatment for Moco deficiency in people.

Children born with mutations that make them unable to synthesize Moco suffer lethal neurological and developmental defects. Providing them supplemental Moco might reverse these devastating symptoms. This work suggests a potential new route for delivering this essential cofactor.

The researchers carried out studies in C. elegans that were engineered to be deficient in their ability to make Moco. Like humans, C. elegans deficient in Moco die very early in development. Nematodes, however, can also ingest Moco from their diet - a process that is similar to supplementation, as with vitamins. The researchers found that the worms could take in Moco as a range of purified Moco-protein complexes. These included complexes with proteins from bacteria, bread mold, green algae and cow's milk. Ingesting these complexes saved the Moco-deficient worms.

Further, they demonstrated that the Moco-protein complexes were very stable, suggesting it is possible to produce them as a supplement for children born with Moco deficiency.

"We tested four proteins and all four were restorative in our nematode model. That's very encouraging," says Kurt Warnhoff, PhD, an investigator in the Department of Molecular Biology at Massachusetts General Hospital (MGH) and the paper's co-lead author. "We do not want to overstate our findings, especially as they relate to patients, but we are extremely excited about the therapeutic and fundamental implications of this work."

Credit: 
Massachusetts General Hospital

Scholars link diet, dentition, and linguistics

Anthropologist Caleb Everett and former student Sihan Chen used a novel data analysis of thousands of languages, in addition to studying a unique subset of celebrities, to reveal how a soft food diet--contrasted with the diet of hunter-gatherers--is restructuring dentition and changing how people speak.

Their findings, published in Scientific Reports, counter the longstanding belief within the field that maintains that languages are susceptible to the same pressures and so are essentially immune to external factors.

"Our results represent the most compelling evidence to date that languages are very much affected by external factors that differ across populations," said Everett, professor and chair of the Department of Anthropology at the University of Miami.

"Languages change--we can see this in any language--but the thinking has long been that all languages have the same pressures, that there is no difference across populations that make some people more prone than others to use certain sounds," he noted.

Everett said that in the past decade, he and others have produced new evidence suggesting that there might be other factors that are likely to influence speech patterns. He highlighted a "highly publicized" paper published in Science Magazine two years ago, while noting that in addition to this new research, he has spent several years studying how environmental factors such as ambient aridity--extreme dryness--shift speech patterns by reducing vowel usage, which requires more effort to pronounce.

He credited the linguistic acumen and diligence of Chen, his former student now pursuing a doctorate in cognitive science, with advancing the dentition study.

"Sihan took a linguistics course and fell in love with the study of languages. An exceptionally bright student, he demonstrated an incredible aptitude for phonetics and transcribing precisely what's going on in people's mouths as they speak," said Everett, who holds a secondary appointment in psychology.

Yet changes in language take hundreds of years to emerge, Everett explained. So, to obtain a quicker accounting, the two examined the speech patterns of 10 celebrities--including British singing phenom Freddie Mercury and former Olympic swimmer Michael Phelps--a research subset that offered a spectrum of dentition variance.

Mercury's four additional teeth--a hereditary dental condition--caused a famously unusual overbite. (Mercury was embarrassed by the protrusion but resisted any oral surgery believing the anomaly contributed to his exceptional four-octave vocal range.) And Phelps also presented a unique alignment issue.

Everett recognized that, from a research standpoint, utilizing the data from the 10 celebrities was "a bit tricky."

"Freddie Mercury's bite isn't the way that it is because of his diet; there are obviously genetic factors here," he said. "Yet the data from the celebrities provides us insight in real time and contributes to understanding this story of human language that is changing over time."

Additionally, using the publicly accessible videos created a research trail that allowed others to check the data and transcriptions, Everett noted, adding, "the pattern was a lot clearer than I would have expected."

In meticulously transcribing the online videos of the celebrities, Chen focused on establishing the ratio of labiodental sounds such as "f" and "v"--sounds common today but that rarely existed until soft diets became pervasive. Mercury in particular was known to pronounce these particular sounds with abnormal frequency due to his dental abnormality.

"He was really an extreme because he produced these labiodental sounds all over the place even when they shouldn't be there," Everett said. "On the other end of the spectrum Michael Phelps is kind of doing the reverse."

In studying thousands of languages, the researchers established two linguistic camps--hunter-gatherers, whose diets have changed little and whose mouths get a lot more wear, and non-hunter-gatherers. Everett's extensive previous research on indigenous peoples in the Amazon--whose diets remain akin to those of hunter-gatherers--aided the study.

Previous research on the subject has examined whether languages have this sound, or they don't. Everett and Chen delved deeper, analyzing the ratios of frequency between the two research groups.

"We basically adopted a whole new series of methods to test this and we found extensive support for it," he said, yet emphasized that the findings show correlational, not causal, links between diet, dentition, and speech patterns.

"These pressures are subtle and operate over hundreds and thousands of years, so it's a hard thing to know for sure," he said. "But what we see are these probabilistic tendencies in the worlds 7,000 languages.

"These new findings provide a better understanding of why languages--which are a key distinguishing characteristic for anthropologists and a key aspect of being human--take the shape they do, how they diverge, and what factors impact their evolvement," Everett said.

Credit: 
University of Miami

Journal of Clinical Sleep Medicine collection highlights 15 years of scientific discovery

DARIEN, IL - Editors of the Journal of Clinical Sleep Medicine have identified some of the most significant articles in the publication's history, publishing new commentaries on them in a special 15th anniversary collection. The 15 commentaries from associate editors and members of the journal's editorial board describe the impact of the selected articles both at the time of their publication and today.

"The collection highlights some of the most influential publications in clinical sleep research over the past 15 years," JCSM Editor-in-Chief Dr. Nany Collop said. "These studies underscore the remarkable breadth of our field and display the intellectual curiosity and scientific rigor of talented sleep researchers."

First published by the American Academy of Sleep Medicine in 2005, JCSM has grown significantly from its first year, when 22 original articles were published. In 2020 the monthly journal published more than 200 scientific investigations and case reports. The 15th anniversary collection highlights peer-reviewed, original research papers on sleep disorders such as obstructive sleep apnea, insomnia, narcolepsy, and restless legs syndrome. The selected papers also cover other wide-ranging topics including opioids, school start times, caffeine, melatonin, and the impact of binge-watching on sleep.

The most highly cited article is on sleep deprivation: "Behavioral and physiological consequences of sleep restriction," written by Banks and Dinges in 2007. In the commentary, AASM Past President Dr. Nathaniel Watson and sleep scientist Hans Van Dongen, who has a doctorate in chronobiology and sleep, write that this landmark review "crystallized the problem of short sleep from basic science to epidemiology."

Collop and the journal's founding editor, Dr. Stuart Quan, assessed the most-cited and viewed articles, which associate editors helped narrow to the final selection of 15 studies. An expert on each manuscript topic was invited to prepare a commentary on the paper, describing its impact and influence since its original publication.

Credit: 
American Academy of Sleep Medicine

<i>New England Journal of Medicine</i> publishes COVID-19 treatment trial results

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine. Six researchers from UT Health San Antonio and University Health are coauthors of the publication because of the San Antonio site's sizable patient enrollment in the trial.

The Adaptive COVID-19 Treatment Trial 2 (ACTT-2), which compared the combination therapy versus remdesivir paired with an inactive placebo in hospitalized COVID-19 patients, was supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

Significantly, patients on high oxygen by nasal canula or receiving breathing assistance with a mask when they were enrolled in the study had a time to recovery of 10 days with combination treatment versus 18 days with remdesivir and placebo.

Investigators also saw a difference in patient survival. The 28-day death rate was 5.1% in the combination therapy group and 7.8% in the remdesivir placebo group.

"We are making progress in the treatment of COVID-19," said principal investigator Thomas Patterson, MD, professor and chief of infectious diseases in the Joe R. and Teresa Lozano Long School of Medicine at UT Health San Antonio. "Remdesivir markedly improved recovery of critically ill patients in the first ACTT study, and baricitinib further helped patients in this second study."

Remdesivir is a direct-acting antiviral drug, whereas baricitinib is an anti-inflammatory medicine.

"I think this combination is good for a couple of reasons," Dr. Patterson said. "Baricitinib, as opposed to other anti-inflammatory drugs, has activity itself against the virus. Second, it is a pretty specific inhibitor of the inflammation."

Baricitinib is approved for the treatment of patients with active rheumatoid arthritis. The U.S. Food and Drug Administration issued an emergency use authorization on Nov. 19, 2020, for baricitinib, in combination with remdesivir, for the treatment of suspected or laboratory-confirmed COVID-19 in hospitalized adults and pediatric patients 2 years of age or older requiring supplemental oxygen, invasive mechanical ventilation or extracorporeal membrane oxygenation.

"We do these clinical trials to accomplish a goal, and that is to save lives," Dr. Patterson said. "At the beginning of the pandemic, we were losing a lot of patients who we are now saving, so we are getting closer to our goal."

Credit: 
University of Texas Health Science Center at San Antonio

Snakes evolve a magnetic way to be resistant to venom

image: The Sudanase red spitting cobra, another predator analysed in Dr Fry's study.

Image: 
Bonnerscar

Certain snakes have evolved a unique genetic trick to avoid being eaten by venomous snakes, according to University of Queensland research.

Associate Professor Bryan Fry from UQ's Toxin Evolution Lab said the technique worked in a manner similar to the way two sides of a magnet repel each other.

"The target of snake venom neurotoxins is a strongly negatively charged nerve receptor," Dr Fry said.

"This has caused neurotoxins to evolve with positively charged surfaces, thereby guiding them to the neurological target to produce paralysis.

"But some snakes have evolved to replace a negatively charged amino acid on their receptor with a positively charged one, meaning the neurotoxin is repelled.

"It's an inventive genetic mutation and it's been completely missed until now.

"We've shown this trait has evolved at least 10 times in different species of snakes."

The researchers found that the Burmese python - a slow-moving terrestrial species vulnerable to predation by cobras - is extremely neurotoxin resistant.

"Similarly, the South African mole snake, another slow-moving snake vulnerable to cobras, is also extremely resistant," Dr Fry said.

"But Asian pythons which live in trees as babies, and Australian pythons which do not live alongside neurotoxic snake-eating snake, do not have this resistance.

"We've long known that some species - like the mongoose - are resistant to snake venom through a mutation that physically blocks neurotoxins by having a branch-like structure sticking out of the receptor, but this is the first time the magnet-like effect has been observed."

"It has also evolved in venomous snakes to be resistant to their own neurotoxins on at least two occasions."

The discovery was made after the establishment of UQ's new $2 million biomolecular interaction facility, the Australian Biomolecular Interaction Facility (ABIF).

"There's some incredible technology at the ABIF allowing us to screen thousands of samples a day," Dr Fry said.

"That facility means we can do the kinds of tests that would have just been science fiction before, they would have been completely impossible."

Credit: 
University of Queensland

Bio-inspired spiral hydrogel fiber qualified to be surgical suture

"The lotus roots may break, but the fiber remains joined" is an old Chinese saying that reflects the unique structure and mechanical properties of the lotus fiber. The outstanding mechanical properties of lotus fibers can be attributed to their unique spiral structure, which provides an attractive model for biomimetic design of artificial fibers.

In a new study published in Nano Letters, a team led by Prof. YU Shuhong from the University of Science and Technology of China (USTC) of the Chinese Academy of Sciences (CAS) reported a bio-inspired lotus-fiber-mimetic spiral structure bacterial cellulose (BC) hydrogel fiber with high strength, high toughness, excellent biocompatibility, good stretchability, and high energy dissipation.

Unlike polymer-based hydrogel, the newly designed biomimetic hydrogel fiber (BHF) is based on the BC hydrogel with 3D cellulose nanofiber networks produced by bacteria. The cellulose nanofibers provide the reversible hydrogen bonding network that results in unique mechanical properties.

The researchers applied a constant tangential force to the pretreated BC hydrogel along the cross-sectional direction. Then, the two sides of the hydrogel were subjected to opposite tangential forces, and local plastic deformation occurred.

The hydrogen bonds in the 3D network of cellulose nanofibers were broken by the tangential force, causing the hydrogel strip to twist spirally and the network to slip and deform. When the tangential force was removed, the hydrogen bonds reformed between the nanofibers, and the spiral structure of the fiber was fixed.

Benefited from lotus-fiber-mimetic spiral structure, the toughness of BHF can reach ?116.3 MJ m-3, which is more than nine times higher than those of non-spiralized BC hydrogel fiber. Besides, once the BHF is stretched, it is nearly non-resilient.

Combining outstanding mechanical properties with excellent biocompatibility derived from BC, BHF is a promising hydrogel fiber for biomedical material, especially for surgical suture, a commonly used structural biomedical material for wound repair.

Compared with commercial surgical suture with higher modulus, the BHF has similar modulus and strength to soft tissue, like skin. The outstanding stretchability and energy dissipation of BHF allow it to absorb energy from the tissue deformation around a wound and effectively protect the wound from rupture, which makes BHF an ideal surgical suture.

What's more, the porous structure of BHF also allows it to adsorb functional small molecules, such as antibiotics or anti-inflammatory compounds, and sustainably release them on wounds. With an appropriate design, BHF would be a powerful platform for many medical applications.

Credit: 
University of Science and Technology of China

Illinois residents value strategies to improve water quality

image: Illinois residents are willing to pay for improved water quality in the Sangamon River and beyond, a new University of Illinois study shows.

Image: 
College of ACES, University of Illinois.

URBANA, Ill. ¬- Illinois residents value efforts to reduce watershed pollution, and they are willing to pay for environmental improvements, according to a new study from agricultural economists at the University of Illinois.

Nutrient runoff from agricultural production is a major cause of pollution in the Mississippi River Basin and contributes to hypoxia - limited oxygen to support sea life in the Gulf of Mexico. The U.S. Environmental Protection Agency (EPA) set up action plans to reduce pollution in 12 midwestern states and reduce transmissions of nitrate-nitrogen and phosphorus by 45% in 2040.

Illinois agencies have established the Illinois Nutrient Loss Reduction Strategy (INLRS) to address those issues, relying on voluntary efforts as well as policy measures such as state subsidies. Understanding the level of support from local residents can help inform nutrient reduction initiatives.

"We know water quality is important and water pollution has costs in terms of both health and economic damages," says Bryan Parthum, lead author on the paper. Parthum was a graduate student in the Department of Agricultural and Consumer Economics at U of I when the study was conducted; he now works as an economist in the EPA Office of Policy.

"We wanted to find out how much people care about local water quality, fish populations, and algal blooms, and how much they care about meeting EPA targets which benefit the Gulf of Mexico," Parthum explains.

The researchers surveyed respondents in the Upper Sangamon River Watershed in Central Illinois, an INLRS priority watershed due to high levels of nitrate and phosphorus transmission.

Respondents completed a choice experiment survey containing different scenarios that described water quality improvements such as reducing algal bloom, increasing the overall fish population and number of fish species, and meeting EPA targets for reducing nutrient pollution.

The scenarios also included information about proximity to the respondent, and a range of potential costs associated with those measures.

The researchers could then estimate how much people were willing to pay for the various improvements. For example, a 50% reduction of algal blooms in the watershed would, on average, be worth $32 annually per household.

"And if you combine reduced algal blooms, improved fish population and diversity, and meeting the nutrient targets, that whole bundle is worth $85 per household," Parthum says.

Amy Ando, professor of agricultural and consumer economics at U of I and co-author of the paper, notes the Sangamon River isn't known as a tourist destination, yet still holds value for recreational purposes. Close to 50% of respondents indicated using the river for fishing, boating, or hiking at least once a year.

"The actions taken by the INLRS, if successful, will reduce hypoxia in the Gulf of Mexico, and people in Illinois care about doing that. But the strategies also have value for improvements in fish populations and reductions in algal blooms right here at home, so people get some local benefits as well," Ando notes.

The survey included 373 respondents, about evenly divided between urban and rural residents. The researchers observed no difference in attitudes towards water policy measures among the two groups.

"There may be a perception that urban residents care more about environmental improvements. But we found both urban and rural groups expressed value for improved fish populations and water quality in the rivers that run through where they live," Ando says.

Credit: 
University of Illinois College of Agricultural, Consumer and Environmental Sciences